Funding Rounds
Reapplix

Reapplix Series A (2020, $22M)

Reapplix

Technology that identifies blood-derived proteins to enhance wound healing for patients with chronic wounds.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $22.60M

Raised Date: 2020-01-01